c-myc reverses neu-induced transformed morphology by transcriptional repression.
about
A cofactor, TIP30, specifically enhances HIV-1 Tat-activated transcriptionRB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2.Myc-mediated transformation: the repression connection.Mechanisms of apoptosis by c-Myc.Heregulin negatively regulates transcription of ErbB2/3 receptors via an AKT-mediated pathwayDifferential modulation of cyclin gene expression by MYCThe Myc negative autoregulation mechanism requires Myc-Max association and involves the c-myc P2 minimal promoter.Determination of c-myc amplification and overexpression in breast cancer patients: evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological characteristics using univariate and multivariate analysisRepression of cyclin D1: a novel function of MYCIdentification and characterization of a novel enhancer for the rat neu promoter.Negative autoregulation of the neu gene is mediated by a novel enhancer.Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology.c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis.Functional analysis of Burkitt's lymphoma mutant c-Myc proteins.L-myc and N-myc in hematopoietic malignancies.Characterization of a repressor element and a juxtaposed tissue-restricted activator element located on the distal neu gene promoter.Transcriptional suppression of HLA-B expression by c-Myc is mediated through the core promoter elements.Expression of the neu proto-oncogene by Schwann cells during peripheral nerve development and Wallerian degeneration.Regulation of the ERBB-2 promoter by RBPJkappa and NOTCH.Oestrogen and epidermal growth factor down-regulate erbB-2 oncogene protein expression in breast cancer cells by different mechanisms.The Epstein-Barr virus nuclear antigen-1 may act as a transforming suppressor of the HER2/neu oncogene.Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas
P2860
Q24314052-067975B7-1D77-46AE-9AEF-2393B8C98147Q24522518-46682296-4BAC-43E0-B9FB-0452A9FB1675Q33667285-578D1ACA-16B4-4DAA-9D5E-102131FCCF6AQ33667315-DE33751F-E14E-48FD-B0D7-D342BFD48684Q35535547-B59E423A-00C0-40A3-B756-38F30AD61B95Q36258572-91FD7E3E-7C4F-461B-8C14-31190AC1456CQ36564631-D6214EE8-5BB8-4FEB-A4B0-A59C695C8AC8Q36619981-0CF63E1C-93CC-4A8C-9B18-F1F02C0F933EQ36654990-AEE285B6-F091-4299-999F-76970CC4D80DQ36687823-C1E2EF34-8DFE-40EC-A36D-B1F83E5E7833Q36817452-1FB894F9-41E1-400A-954C-84CEAEE060C1Q37825724-FBE06C9C-11AD-4FE6-867E-2679A31BA1CEQ37833424-4881B889-1EA0-4F3F-AE4C-07A8D5C79A15Q38360599-923BFCBE-BCD6-42D4-A6AE-598332D6E882Q40790440-680C3BD0-5DF2-4B3C-8124-4D7AA3BF444EQ40897772-D2180EAF-F194-49E6-B04D-D9F24E36D591Q41498084-9AA1B333-CE1C-4AD0-8ED9-4FACFBFCF793Q41632542-4CE5FAFA-C1B9-47C8-B141-42414AAC57F7Q42438785-7A85C98D-1C6D-46C1-981B-E031DDCE640FQ42590519-213C949F-0A73-4B19-B624-4E2EDBAA873FQ42807720-DA5A3409-0441-4BAF-83BE-2474B6074FFBQ55670934-D97E0EA2-BC74-410C-8910-2B9A487EB16B
P2860
c-myc reverses neu-induced transformed morphology by transcriptional repression.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
c-myc reverses neu-induced transformed morphology by transcriptional repression.
@ast
c-myc reverses neu-induced transformed morphology by transcriptional repression.
@en
type
label
c-myc reverses neu-induced transformed morphology by transcriptional repression.
@ast
c-myc reverses neu-induced transformed morphology by transcriptional repression.
@en
prefLabel
c-myc reverses neu-induced transformed morphology by transcriptional repression.
@ast
c-myc reverses neu-induced transformed morphology by transcriptional repression.
@en
P2860
P356
P1476
c-myc reverses neu-induced transformed morphology by transcriptional repression.
@en
P2093
P2860
P304
P356
10.1128/MCB.11.1.354
P407
P577
1991-01-01T00:00:00Z